Medication Abortion Health Risks Late-Term Abortion Fetal Viability Legal Framework Medical Emergencies Pregnancy Legal Regulations Medication Abortions Legal Restrictions Medical Abortion Medical Ethics Abortion Access Mental Health Abortion Restrictions Dilation and Evacuation Medical Necessity Safety Standards Health Policy Medical Professionals Maternal Health Medical Care Access Abortion Bans Patient Rights Health Care Access Fetal Development Medical Regulations Late-term Abortion Emergency Medical Care Legal Implications of Abortion Health Risks of Abortion Self-managed Abortion Trimesters Women's Health Risks Medical Risks Impact on Women Legal Battles Legal Status Viability Access to Abortion Medical Guidelines Pregnancy Complications Medical Supervision Historical Abortion Practices Reproductive Freedoms Mifepristone Illegal Abortions Dilation and Curettage Survivors of Abortion Legal Exceptions Foetal Viability Legal Abortion Medical Treatments Chemical Abortion Viability Standards Health Policies Healthcare Access Abortion Regulations Medical Complications Risks and Complications Second-Trimester Abortion Abortion Pills Late-Term Abortions
The ruling applies Prop. 139’s standard, immediately restoring access curtailed by pre‑viability limits.
